Johan Vansteenkiste Selected Research

Breast Neoplasms (Breast Cancer)

11/2021	Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study.
12/2018	Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan Vansteenkiste Research Topics

Disease

78	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023 - 07/2002
55	Neoplasms (Cancer) 01/2022 - 08/2002
22	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2002
17	Disease Progression 01/2021 - 10/2005
16	Anemia 05/2023 - 08/2002
6	Neutropenia 05/2023 - 05/2007
6	Pneumonia (Pneumonitis) 01/2023 - 01/2009
5	Febrile Neutropenia 05/2023 - 05/2007
5	Neoplasm Metastasis (Metastasis) 12/2019 - 11/2010
5	Exanthema (Rash) 04/2015 - 04/2007
4	Adenocarcinoma 05/2023 - 07/2008
4	Diarrhea 04/2015 - 04/2007
4	Melanoma (Melanoma, Malignant) 03/2014 - 07/2011
3	Thrombocytopenia (Thrombopenia) 05/2023 - 05/2007
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 03/2006
3	Fatigue 01/2018 - 08/2002
3	Adenocarcinoma of Lung 08/2015 - 02/2011
2	Alopecia (Baldness) 05/2023 - 07/2008
2	Nausea 05/2023 - 07/2008
2	Large Cell Carcinoma 05/2023 - 07/2008
2	Inflammation (Inflammations) 01/2022 - 11/2018
2	Breast Neoplasms (Breast Cancer) 11/2021 - 12/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2018
2	Dehydration (Water Stress) 11/2018 - 03/2014
2	Infections 11/2018 - 05/2007
2	Vomiting 01/2018 - 03/2014
2	Hemorrhage 02/2011 - 05/2007
2	Hypoxia (Hypoxemia) 07/2009 - 06/2007
1	Carcinoid Tumor (Carcinoid) 05/2022
1	Necrosis 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Acute Tubulointerstitial Nephritis 01/2020

Drug/Important Bio-Agent (IBA)

14	Cisplatin (Platino)FDA LinkGeneric 05/2023 - 07/2002
13	Darbepoetin alfa (Aranesp)FDA Link 01/2016 - 08/2002
11	Pemetrexed (MTA)FDA Link 05/2023 - 05/2007
10	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2003
9	Hemoglobins (Hemoglobin)IBA 01/2016 - 08/2002
8	AntigensIBA 01/2019 - 07/2011
7	Gemcitabine FDA Link 05/2023 - 05/2003
7	osimertinibIBA 01/2023 - 08/2018
7	PlatinumIBA 11/2021 - 08/2007
7	Docetaxel (Taxotere)FDA Link 01/2021 - 04/2008
7	HematinicsIBA 04/2013 - 06/2009
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2009
4	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2015
4	Gefitinib (Iressa)FDA Link 01/2023 - 06/2003
4	LigandsIBA 05/2022 - 01/2014
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2014
4	VaccinesIBA 03/2014 - 07/2011
3	durvalumabIBA 01/2020 - 01/2018
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2019 - 10/2002
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 07/2011
3	Monoclonal AntibodiesIBA 01/2017 - 01/2014
3	ceritinibIBA 04/2016 - 03/2014
3	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 06/2007
3	belagenpumatucel LIBA 03/2014 - 07/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 08/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2014
2	avelumabIBA 01/2021 - 11/2018
2	pyrimidineIBA 05/2019 - 01/2017
2	AntibodiesIBA 11/2018 - 01/2014
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 03/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 01/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 02/2015
2	Transaminases (Aminotransferases)IBA 01/2018 - 03/2014
2	atezolizumabIBA 01/2017 - 04/2016
2	AZD 6244IBA 01/2017 - 01/2013
2	B7-H1 AntigenIBA 01/2017 - 04/2016
2	CrizotinibIBA 04/2016 - 03/2014
2	Etoposide (VP 16)FDA LinkGeneric 03/2016 - 01/2009
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 07/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2015 - 04/2007
2	L-BLP25IBA 06/2014 - 01/2014
2	taxaneIBA 08/2008 - 08/2007
2	Vindesine (Vindesin)IBA 05/2003 - 07/2002
1	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2020
1	capmatinibIBA 01/2020
1	CollagenIBA 01/2020

Therapy/Procedure

41	Drug Therapy (Chemotherapy) 05/2023 - 07/2002
36	Therapeutics 01/2020 - 08/2002
15	Immunotherapy 01/2023 - 07/2013
9	Radiotherapy 12/2016 - 07/2002
6	Induction Chemotherapy 01/2014 - 11/2005
5	Chemoradiotherapy 01/2023 - 01/2009
4	Adjuvant Chemotherapy 01/2016 - 01/2004
2	Aftercare (After-Treatment) 12/2018 - 11/2018
2	Immunomodulation 10/2015 - 01/2014
2	Erythrocyte Transfusion 04/2013 - 11/2012
2	Thoracotomy 11/2010 - 01/2009
1	Neoadjuvant Therapy 01/2020